WORKING WITH US

We welcome potential investments in MedTech, including therapeutic devices, diagnostics, and related technologies.

We seek ventures with the potential to address significant markets that enable paradigm shifts in diagnosis and treatment, and reduce the costs of healthcare delivery.

How to Submit Materials:

We try to review all materials within three to four weeks of submission, after which we will provide an indication of our level of interest and potentially request additional data. During our review process, materials are read by the investment team and discussed at weekly meetings. Investments must be unanimously approved by the investment committee.

We do not sign confidentiality agreements until after we have determined interest in a potential investment.

Please be aware that we review hundreds of potential investments each year, so that many submissions, even though investment grade, are passed on because they do not meet the specific needs of our portfolio.

Initial submissions should include material addressing the key criteria noted above. Materials may be submitted directly to any BioVentures investment professional, or to connect with us via email. We prefer electronic submissions in all cases.